Skip to main content
All lobbying filings

GEISINGER HEALTH AND VARIOUS SUBSIDIARIES

Lobbying for GEISINGER HEALTH

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 16, 2026
Expenses
$120,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Pennsylvania

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues related to the impact of H.R. 1, One Big Beautiful Bill Act, on Medicaid and Medicare funding; Issues related to H.R. 9544, (Save MEDICARE Act of 2026); Issues related to CMS's Medicaid Quality Pledge for states; Issues related to Medicare & Medicaid Reimbursement; Issues related to Health care and biomedical research funding; Issues related to CY2027 Outpatient Prospective Payment System proposed rule; Issues related to Medicaid program data collection requirements; Issues related to overpayment recovery.

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem